Crispr Therapeutics Ag (CRSP)

$57.92 0.35 (0.61%)

16:00 EDT CRSP Stock Quote Delayed 30 Minutes

3 Gene Editing Stocks Shaping the Future of Medicine

By Muslim Farooque, InvestorPlace Contributor Jul 22, 2024

Gene editing stocks offer a bold venture into biopharma's future, leveraging CRISPR technology for transformative healthcare solutions

3 Gene Editing Stocks That Could Grow Your Wealth

3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition

3 Profitable CRISPR Stocks Earning Analysts’ Praise

Volume:

Previous Close -

Market Cap 4.57B

PE Ratio -86.45

EPS -0.67

Volume (Avg. Vol.) 867,106

Day's Range $57.35 - $59.77

52-Week Range $37.55 - $91.10

Dividend & Yield N/A (N/A)

CRSP Stock Predictions, Articles, and Crispr Therapeutics Ag News

7 Growth Stocks to Invest $500 In and Cash Out $100K by 2030

By Omor Ibne Ehsan Jul 9, 2024

Investing $500 in these seven high-growth stocks could potentially turn into $100,000 by 2030, offering massive upside.

The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024

By Chris Markoch, InvestorPlace Contributor Jul 9, 2024

Finding undervalued gene editing stocks is easy, but having the patience to stick with them is the challenge

3 Top-Rated Gene Editing Stocks Actually Making Money

By Alex Sirois, InvestorPlace Contributor Jul 3, 2024

Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.

You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.

By Viktor Zarev, InvestorPlace Contributor Jun 27, 2024

The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects.

Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich

By Chris Markoch, InvestorPlace Contributor Jun 27, 2024

These three biotech stocks to buy carry risks but may appeal to speculative investors with time and patience.

You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.

By Muslim Farooque, InvestorPlace Contributor Jun 27, 2024

Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.

3 Biotech Stocks That Could Make Your Grandchildren Rich

By Mohammed Saqib, InvestorPlace Contributor Jun 27, 2024

These biotech stocks are poised to generate significant returns to investors due to their high growth potential.

Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich

By Ian Cooper, InvestorPlace Contributor Jun 26, 2024

Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks.

3 Gene Editing Stocks That Could Make Your Grandchildren Rich

By Matthew Farley, InvestorPlace Contributor Jun 25, 2024

Explore gene-editing stocks with long-term growth potential, offering innovative solutions to previously untreatable conditions.

The Next Big Thing After AI? 3 Sleeper Stocks to Buy Before the Boom

By Omor Ibne Ehsan Jun 24, 2024

These three sleeper stocks could deliver massive gains if their cutting-edge technologies take off in the coming years.

7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom

By Josh Enomoto, InvestorPlace Contributor Jun 12, 2024

Because it’s tied to one of the six leading causes of “finality,” stress represents a silent public health crisis. And few things cause heightened stress…

7 Stocks You Haven’t Heard of (That EVERYONE Should Own)

By Omor Ibne Ehsan May 29, 2024

These under-the-radar must-own stocks across various sectors are using powerful megatrends and posting solid financial results.

7 Biotech Stocks to Put on Your Breakthrough Radar

By Josh Enomoto, InvestorPlace Contributor May 27, 2024

For those seeking to decipher best speculative opportunities in the market, biotech stocks with breakthrough potential may offer plenty of firepower. Let’s get some of…